AOD-9604 AOD

A modified fragment of growth hormone marketed for fat loss without growth hormone's other effects. The company that developed it ran human trials, and those trials found it caused no more fat loss than a placebo, despite it remaining popular in research-chemical circles.

Also known as Anti-obesity drug 9604, AOD 9604, RefChem:113278, Tyr-somatostatin (177-191), Somatostatin (177-191), Tyr-, Somatostatin (177-191), tyrosyl-, 7UP768IP4M, orb1910051, EX-A4625

Effects Lose fat

Routes Subcutaneous

Legal status Research chemical

WADA Banned at all times

Molecular Structure of C₇₈H₁₂₃N₂₃O₂₃S₂

Drag to rotate · scroll to zoom

Chemistry

Formula: C78H123N23O23S2
Molar mass: 1815.1
CAS: 221231-10-3
PubChem CID: 71300630
IUPAC name: (2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]amino]-22-(3-carbamimidamidopropyl)-13-(2-carboxyethyl)-7,19-bis(hydroxymethyl)-6,9,12,15,18,21,24-heptaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenylpropanoic acid
InChIKey: GVIYUKXRXPXMQM-BPXGDYAESA-N